Diabetes Australia supporting research into the causes of type 1 diabetes 23 January 2019 With the support of a grant from the Diabetes Australia Research Trust, Dr Andrew Sutherland from St Vincent’s Institute Medical Research is studying a new way of potentially preventing and treating type 1 diabetes. “There are a class of immune cells, Th17, that can play a role in the development of type 1 diabetes so we want to identify the molecules these cells produce. This could pave the way for the development of new therapies,” Dr Sutherland said. “My research will be looking specifically at IL-17F, a protein produced by Th17 that is responsible for cell signaling, that hasn’t previously been studied in type 1 diabetes. “We have shown that IL-17F causes the dysfunction and death of pancreatic beta cells which may be an important pathway that leads to type 1 diabetes. “Hopefully, if we can inhibit the function of IL-17F then we can prevent or treat type 1 diabetes in mice. “If it works in the mouse model, then IL-17F inhibitors could be good candidates for a clinical trial of a drug to prevent type 1 diabetes.”
Media releases 13 February 2025 Diabetes Australia calls for election commitments to improve tech access Diabetes Australia representatives are in Federal Parliament this week calling on both sides of politics to commit to funding equitable... Continue Reading
News 4 February 2025 Urgent calls for diabetes funding in 2025-26 Federal Budget The Diabetes Alliance has called on the Federal Government to commit to, and fund, the recommendations of the Parliament Inquiry... Continue Reading
Blog 2 February 2025 Diabetes-friendly guide to shedding those extra Christmas kilos Follow this diabetes-friendly guide to shedding those extra kilos and regaining control of your health. Continue Reading